Insider selling is routine at these dollar levels and does not signal fundamental deterioration. However, the pattern of multiple C-suite officers selling in the same window near all-time highs suggests insiders may view the current valuation as full. Monitor next earnings for any guidance changes or competitive developments in the liquid biopsy space.
Price Chart
Executive Summary
Two C-suite executives at Natera (President of Clinical Diagnostics and President/Chief Business Officer) sold a combined $360K in open-market sales on April 27, 2026, at $203.75 per share. This follows a broader cluster of insider selling by the CEO, directors, and other officers totaling ~$1.5M over the prior week. While the dollar amount is trivial relative to Natera's $28.6B market cap (0.0013%), the concentration of selling by senior leadership near the stock's recent highs warrants attention.
Key Financial Metrics
Key Facts
- President of Clinical Diagnostics Solomon Moshkevich sold 997 shares for $203K on April 27
- President and Chief Business Officer John Fesko sold 771 shares for $157K on April 27
- Total open-market sales in this cluster: $360K
- Prior week saw CEO Steven Chapman sell $463K and other insiders sell $680K
- Total insider selling over 7 days: ~$1.5M, or 0.005% of market cap
- Non-cash director grants of 728 shares on April 24 have zero economic impact
- Natera has 89% analyst bullish rating with $28.6B market cap
Financial Impact
Total insider selling of $360K in this cluster, $1.5M over 7 days — immaterial relative to $28.6B market cap
Risk Factors
- Insider selling cluster may indicate management sees limited near-term upside at current valuation
- No insider buying to offset selling pattern — one-sided selling by leadership
- Historical calibration shows bearish calls on NTRA have underperformed (29% win rate at T+20)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NTRA-1777512943325 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | Insider Cluster | $328.18 $341.79 | ▲ +4.15% | ▲ +5.36% | $410.35 (+25.04%) |
Aug 29, 2026 4w ago | Insider Cluster | $321.96 $328.59 | ▼ −2.06% | ▼ −2.20% | $410.35 (−27.45%) |
Aug 15, 2026 6w ago | Insider Cluster | $314.18 $327.72 | ▲ +4.31% | ▲ +5.50% | $410.35 (+30.61%) |
Aug 8, 2026 7w ago | Insider Cluster | $318.35 $314.18 | ▼ −1.31% | ▼ −1.26% | $410.35 (+28.90%) |
Aug 6, 2026 8w ago | Insider Cluster | $265.38 $310.78 | ▼ −17.11% | ▼ −15.89% | $410.35 (−54.63%) |
Jul 30, 2026 9w ago | Insider Cluster | $269.66 $265.38 | ▼ −1.59% | ▼ −5.21% | $410.35 (+52.17%) |
Jul 18, 2026 10w ago | Insider Cluster | $262.63 $261.99 | ▼ −0.24% | ▲ +0.18% | $410.35 (+56.25%) |
Jul 16, 2026 11w ago | Insider Cluster | $269.83 $264.69 | ▼ −1.90% | ▼ −0.23% | $410.35 (+52.08%) |
Jul 9, 2026 12w ago | Insider Cluster | $281.85 $269.83 | ▼ −4.26% | ▼ −4.13% | $410.35 (+45.59%) |
Jul 7, 2026 12w ago | Insider Cluster | $281.27 $272.66 | ▼ −3.06% | ▼ −3.61% | $410.35 (+45.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access